Log in

NASDAQ:SRRK - Scholar Rock Stock Price, Forecast & News

-1.64 (-10.89 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
Now: $13.42
50-Day Range
MA: $14.55
52-Week Range
Now: $13.42
Volume53,500 shs
Average Volume104,014 shs
Market Capitalization$400.05 million
P/E RatioN/A
Dividend YieldN/A
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its lead antibody product candidate is SRK-015, an inhibitor of the activation of myostatin, which is in Phase I clinical trials for the treatment of spinal muscular atrophy. The company is also developing SRK-181, an inhibitor of the activation of transforming growth factor beta-1 to treat cancers resistant to checkpoint blockade therapies. In addition, it is developing a pipeline of novel product candidates for a range of serious diseases, including other neuromuscular disorders, cancer, fibrosis, and anemia. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Read More
Scholar Rock logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:SRRK



Sales & Book Value

Annual Sales$20.49 million
Book Value$3.80 per share


Net Income$-51,000,000.00
Net Margins-248.88%


Market Cap$400.05 million
Next Earnings Date5/12/2020 (Estimated)
OptionableNot Optionable

Receive SRRK News and Ratings via Email

Sign-up to receive the latest news and ratings for SRRK and its competitors with MarketBeat's FREE daily newsletter.

Scholar Rock (NASDAQ:SRRK) Frequently Asked Questions

How has Scholar Rock's stock been impacted by COVID-19 (Coronavirus)?

Scholar Rock's stock was trading at $14.86 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SRRK stock has decreased by 9.7% and is now trading at $13.42. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Scholar Rock?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Scholar Rock in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Scholar Rock.

When is Scholar Rock's next earnings date?

Scholar Rock is scheduled to release its next quarterly earnings announcement on Tuesday, May 12th 2020. View our earnings forecast for Scholar Rock.

How were Scholar Rock's earnings last quarter?

Scholar Rock Holding Corp (NASDAQ:SRRK) released its earnings results on Thursday, March, 12th. The company reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.17. The firm earned $7.57 million during the quarter, compared to analyst estimates of $5.45 million. Scholar Rock had a negative return on equity of 44.24% and a negative net margin of 248.88%. View Scholar Rock's earnings history.

What price target have analysts set for SRRK?

3 brokers have issued 1 year target prices for Scholar Rock's shares. Their forecasts range from $27.00 to $35.00. On average, they expect Scholar Rock's share price to reach $31.00 in the next twelve months. This suggests a possible upside of 131.0% from the stock's current price. View analysts' price targets for Scholar Rock.

Has Scholar Rock been receiving favorable news coverage?

Press coverage about SRRK stock has trended somewhat negative recently, InfoTrie reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Scholar Rock earned a news impact score of -1.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutScholar Rock.

Are investors shorting Scholar Rock?

Scholar Rock saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 1,901,200 shares, an increase of 6.2% from the February 27th total of 1,790,000 shares. Based on an average daily trading volume, of 80,500 shares, the days-to-cover ratio is currently 23.6 days. Approximately 9.7% of the company's stock are sold short. View Scholar Rock's Current Options Chain.

Who are some of Scholar Rock's key competitors?

What other stocks do shareholders of Scholar Rock own?

Who are Scholar Rock's key executives?

Scholar Rock's management team includes the following people:
  • Mr. Nagesh K. Mahanthappa Ph.D., Pres, CEO & Exec. Director (Age 54)
  • Mr. Yung H. Chyung, Chief Medical Officer (Age 43)
  • Ms. Rhonda M. Chicko, Chief Financial Officer (Age 53)
  • Mr. Alan J. Buckler, Chief Scientific Officer (Age 59)
  • Ms. Catherine Hu, Exec. Director of Investor Relations & Corp. Communications

When did Scholar Rock IPO?

(SRRK) raised $76 million in an initial public offering on Thursday, May 24th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. Jefferies, Cowen and BMO Capital Markets acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

What is Scholar Rock's stock symbol?

Scholar Rock trades on the NASDAQ under the ticker symbol "SRRK."

Who are Scholar Rock's major shareholders?

Scholar Rock's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Norges Bank (1.36%), State Street Corp (1.19%), Victory Capital Management Inc. (0.84%), Victory Capital Management Inc. (0.83%), Geode Capital Management LLC (0.80%) and Jefferies Group LLC (0.42%). Company insiders that own Scholar Rock stock include Amir Nashat and International SCA Artal. View institutional ownership trends for Scholar Rock.

Which major investors are selling Scholar Rock stock?

SRRK stock was sold by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Marshall Wace LLP, Nuveen Asset Management LLC, Alberta Investment Management Corp, Panagora Asset Management Inc., and Credit Suisse AG. View insider buying and selling activity for Scholar Rock.

Which major investors are buying Scholar Rock stock?

SRRK stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Point72 Asset Management L.P., Victory Capital Management Inc., Victory Capital Management Inc., State Street Corp, Goldman Sachs Group Inc., California Public Employees Retirement System, and Barclays PLC. Company insiders that have bought Scholar Rock stock in the last two years include Amir Nashat, and International SCA Artal. View insider buying and selling activity for Scholar Rock.

How do I buy shares of Scholar Rock?

Shares of SRRK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Scholar Rock's stock price today?

One share of SRRK stock can currently be purchased for approximately $13.42.

How big of a company is Scholar Rock?

Scholar Rock has a market capitalization of $400.05 million and generates $20.49 million in revenue each year. The company earns $-51,000,000.00 in net income (profit) each year or ($1.85) on an earnings per share basis. Scholar Rock employs 65 workers across the globe. View additional information about Scholar Rock.

What is Scholar Rock's official website?

The official website for Scholar Rock is http://www.scholarrock.com/.

How can I contact Scholar Rock?

Scholar Rock's mailing address is 620 MEMORIAL DRIVE 2ND FLOOR, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-259-3860 or via email at [email protected]

MarketBeat Community Rating for Scholar Rock (NASDAQ SRRK)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  242
MarketBeat's community ratings are surveys of what our community members think about Scholar Rock and other stocks. Vote "Outperform" if you believe SRRK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRRK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Featured Article: What is cost of equity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel